Get started
Author

Aishat Olaide Afuye

Observed names: Aishat Afuye, Aishat O. Afuye
ORCID: 0000-0002-5751-3283
Observed ORCID: 0000-0002-5751-3283
OpenAlex ID: A5035362303
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
2022 · Melody Smith, Anqi Dai, et al. · Nature Medicine · 349
Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma
2020 · Kitsada Wudhikarn, M. Lia Palomba, et al. · Blood Cancer Journal · 264
PDF
Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy
2021 · Roni Shouval, Ana Alarcon Tomas, et al. · Journal of Clinical Oncology · 155
DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality
2020 · Kitsada Wudhikarn, Martina Pennisi, et al. · Blood Advances · 142
PDF
Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies
2020 · David Sermer, Connie Batlevi, et al. · Blood Advances · 125
The International Prognostic Index Is Associated with Outcomes in Diffuse Large B Cell Lymphoma after Chimeric Antigen Receptor T Cell Therapy
2020 · Marta Garcia-Recio, Kitsada Wudhikarn, et al. · Transplantation and Cellular Therapy · 52
A Phase II Study of Prophylactic Anakinra to Prevent CRS and Neurotoxicity in Patients Receiving CD19 CAR T Cell Therapy for Relapsed or Refractory Lymphoma
2021 · Jae H Park, Craig S. Sauter, et al. · Blood · 36
Novel Agents May be Preferable to Chemotherapy for Large B-Cell Lymphoma Progressing after CD19-CAR-T: A Multicenter Observational Study
2021 · Ana Alarcon Tomas, Joshua A Fein, et al. · Blood · 11
Author Correction: Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
2022 · Melody Smith, Anqi Dai, et al. · Nature Medicine · 7
PDF
Letermovir Prophylaxis Demonstrates High Efficacy in Adult Cytomegalovirus (CMV) Seropositive Cord Blood Transplant (CBT) Recipients: A Comparison with Pre-Letermovir Era CBT Controls
2019 · Carmen Lau, Ioannis Politikos, et al. · Transplantation and Cellular Therapy · 5
The Intestinal Microbiota Correlates with Response and Toxicity after CAR T Cell Therapy in Patients with B-Cell Malignancies
2021 · Melody Smith, Anqi Dai, et al. · Blood · 4
Double-Unit Cord Blood (CB) Transplantation with Haplo-Identical CD34+ Cells (haplo-dCBT) May Speed Neutrophil Recovery Although Successful Bridging Is Contingent on Close Haplo-Winning CB Unit HLA-Match
2018 · Ioannis Politikos, Sean M Devlin, et al. · Blood · 4
TP53 and CD19-Directed Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Large B-Cell Lymphoma
2021 · Roni Shouval, Ana Alarcon Tomas, et al. · Blood · 2
Therapeutic Cyclosporine-a (CSA) Levels in the First 7 Days after Cord Blood Transplantation (CBT) Are Critical to Prevent Severe Acute Graft-Versus-Host Disease (aGVHD)
2018 · Valkal Bhatt, Ioannis Politikos, et al. · Transplantation and Cellular Therapy · 1
Engrafting Unit-Recipient HLA-Allele Mismatch Is Not Associated with an Increased Risk of Transplant-Related Mortality (TRM) or Inferior Progression-Free Survival (PFS) after Double Unit Cord Blood (CB) Transplantation (dCBT) in Adults with Hematologic Malignancies
2019 · Ioannis Politikos, Sean M. Devlin, et al. · Transplantation and Cellular Therapy
Double-Unit Cord Blood (CB) Transplantation (dCBT) Supplemented with Haplo-Identical CD34+ Cells May be Associated with Enhanced Neutrophil Recovery but Successful Myeloid Bridging Is Strongly Influenced By Haplo CD34+ Cell Dose and Haplo-Winning CB Unit HLA-Match
2019 · Ioannis Politikos, Sean M. Devlin, et al. · Transplantation and Cellular Therapy
A High Degree of Engrafting Unit-Recipient HLA-Allele Mismatch Is Not Associated with an Increased Risk of Transplant-Related Mortality (TRM) or Inferior Progression-Free Survival (PFS) after Double Unit Cord Blood (CB) Transplantation (dCBT) in Adults with Hematologic Malignancies
2018 · Ioannis Politikos, Sean M Devlin, et al. · Blood
Long-Term Follow-Up of Adult Double Unit Cord Blood (CB) Transplantation (dCBT) Recipients Reveals High Rates of Progression-Free Survival after a Novel Cy/ Flu/ Thio/ TBI 400 Intermediate Intensity Conditioning Regimen
2018 · Ioannis Politikos, Sean M. Devlin, et al. · Transplantation and Cellular Therapy
PDF
Analysis of Cytomegalovirus (CMV) Infections in the First 180 Days in Adult Sero-Positive Cord Blood Transplantation (CBT) Recipients Reveals High Infection Rates and Treatment Burden
2018 · Carmen Lau, Ioannis Politikos, et al. · Transplantation and Cellular Therapy
Works count: 19
Citation count: 1,157
H-index: 8
I10-index: 8
Year
Topic
Type